Page last updated: 2024-11-04

vorinostat and Endometrioma

vorinostat has been researched along with Endometrioma in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Endometrioma: An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imesch, P1
Samartzis, EP1
Dedes, KJ1
Fink, D1
Fedier, A1
Kawano, Y1
Nasu, K1
Li, H1
Tsuno, A1
Abe, W1
Takai, N1
Narahara, H1

Other Studies

2 other studies available for vorinostat and Endometrioma

ArticleYear
Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells.
    Fertility and sterility, 2013, Volume: 100, Issue:3

    Topics: Benzodioxoles; Cell Line, Transformed; Cell Proliferation; Depsipeptides; Down-Regulation; Drug Eval

2013
Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
    Human reproduction (Oxford, England), 2011, Volume: 26, Issue:9

    Topics: Acetylation; Adult; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Cycl

2011